Prognostic analysis of brain metastases from primary breast cancer treated with stereotactic radiotherapy
CHEN Xiu-jun, XIAO Jian-ping, LI Xiang-pan, JIANG Xue-song, ZHANG Ye, XU Ying-jie, WANG Shu-lian, LI Ye-xiong
Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Pecking Union Medical College, Beijing 100021, China
Corresponding author:XIAO Jian-ping, Email:jpxiao8@yahoo.com.cn
Objective To explore the prognostic factors of brain metastases from primary breast cancer treated with stereotactic radiotherapy (SRT). Methods Retrospectively analyze 37 brain metastatic patients from primary breast cancer. Among these patients nineteen were treated with stereotactic radiotherapy alone, eight patients were treated with whole brain radiotherapy (WBRT) plus SRT, the other ten patients were intracranial recurrence after WBRT and treated with SRT for salvage. Kaplan-Meier analyses were used to calculate survival time. Logrank and Cox proportional hazards regression analyses were performed for univariate and multivariate analyses. Results The median follow-up time were 11 months and 15 months for the whole group and the alive. The median overall survival time was 11 months (95% CI=6-16. month) for the whole group. The median overall survival time was 13.5 months for the whole group. In univariate analysis, the triple negative breast cancer (χ2=5.95,P=0.004),lower Karnofsky performance score (KPS,χ2=13.85,P=0.000), the interval between the diagnosis of the primary tumor and brain metastases≤30 months (χ2=6.62,P=0.010),high RPA grade (χ2=15.35,P=0.000) and intracranial recurrence after whole brain radiotherapy (χ2=4.43,P=0.035) were negative prognostic factors for brain metastasis of breast cancer treated with stereotactic radiotherapy. In multivariate analyses, the triple negative breast cancer (χ2=9.58,P=0.008),lower KPS (χ2=6.65,P=0.010), and intracranial recurrence after whole brain radiotherapy (χ2=3.95,P=0.047) were negative prognostic factor. Conclusion The triple negative breast cancer, lower KPS, and intracranial recurrence after WBRT were negative prognostic factor for brain metastasis from primary breast cancer treated with SRT.
CHEN Xiu-jun,XIAO Jian-ping,LI Xiang-pan et al. Prognostic analysis of brain metastases from primary breast cancer treated with stereotactic radiotherapy[J]. Chinese Journal of Radiation Oncology, 2012, 21(6): 496-499.
[1] Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol,2004,22:2865-2872. [2] Schouten LJ,Rutten J,Huveneers HA, et al. Incidence of brainmetastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer,2002,94:2698-2705. [3] Lee YT. Patterns of metastasis and natural courses of breast carcinoma. Cancer Metastasis Rev,1985,4:153-172. [4] Tsukada Y, Fouad A, Pickren JW, et al. Central nervous system metastasis from breast carcinoma:autopsy study. Cancer,1983,52:2349-2354. [5] Boogerd W. Central nervous system metastasis in breast cancer. Radiother Oncol,1996,40:5-22. [6] Paul WS, Samuel TC, Penny KS,et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases:a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys,2010,77:655-661. [7] Muacevic A, Kreth FW, Tonn JC, et al. Stereotactic radiosurgery for multiple brain metastases from breast carcinoma. Cancer,2004,100:1705-1711.
[8] Combs SE, Schulz-Ertner D, Thilmann C, et al. Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol,2004,180:590-596. [9] Firlik KS, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for brain metastases from breast cancer. Ann Surg Oncol,2000,7:333-338. [10] Amendola BE, Wolf AL, Coy SR, et al. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast. Cancer J,2000,6:88-92. [11] Lederman G, Wronski M, Fine M. Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma. Breast Cancer Res Treat,2001,65:145-154. [12] Goyal S, Prasad D, Harrell F Jr, et al. Gamma knife surgery for the treatment of intracranial metastases from breast cancer. J Neurosurg,2005,103:218-223. [13] Akyurek S, Chang EL, Mahajan A, et al. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am J Clin Oncol,2007,30:310-314. [14] Norbert K,Devin KB, Michael WM, et al. Gamma knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys,2009,75:1132-1140. [15] Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. J Neurosurg,2011,114:792-800. [16] Laurie G, Charles S, Marvin R, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys,1997,37:745-751. [17] Paul WS, Brian B, Laurie EG, et al. A new prognostic index and comparison to three other indices for patients with brain metastases:an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys,2008,70:510-514. [18] Sperduto PW, Xu Z, Sneed P, et al. The graded prognostic assessment for women with brain metastases from breast cancer (GPA-Breast):a diagnosis-specific prognostic index. Int J Radiat Oncol Biol Phys,2010,78 Suppl:6-7. [19] Scodan RL, Massard C, Jouanneau L, et al. Brain metastases from breast cancer:recursive partitioning analysis of prognostic factors including molecular subtypes and treatment. Int J Radiat Oncol Biol Phys,2010,78 Suppl:4-5. [20] Gupta GP, Mclane A, Steward L, et al. Stereotactic radiosurgery for breast cancer brain metastases:improved outcomes in Her-2. Int J Radiat Oncol Biol Phys,2010,78 Suppl:5.
2012, Vol. 21 
